Skip to content
Search

Latest Stories

PHE warns of increased risk of malaria amidst Covid-19 travel plans

As international travel starts to recover amidst Covid-19 pandemic, the need to ensure protection against malaria for all those potentially exposed will be as great as ever, the Public Health England (PHE) advisory committee on malaria prevention (ACMP) has said in an update on Thursday (June 10).

The PHE body added that it “will keep its advice for travellers to individual countries under review as the situation evolves.


“It may be that due to increased transmission, the risk of malaria acquisition increases for travellers to some areas, with the possibility of re-introduction of malaria to areas recently considered to have interrupted transmission.”

The PHE has recommended health professionals stick to using one resource for country-specific malaria recommendations to optimise consistency of advice. “Whilst we recognise that other sources of advice are available, healthcare professionals working in England, Wales or Northern Ireland are advised to use the ACMP guidelines as their preferred source of guidance for malaria prevention,” the ACMP said in its latest guidance.

The Covid-19 has had a dramatic effect on travel patterns which has inevitably affected the number of malaria cases imported into the UK.

From the second quarter of 2020 onwards the malaria reference laboratory has seen a 70 to 90 per cent reduction in referred cases.

“The full effect of Covid-19 on in-country malaria eradication programmes has yet to be determined, but there are concerns that hard-won gains may be lost,” the PHE said.

The WHO world malaria report 2020 indicates that many countries have reported moderate levels of disruptions.

From modelling data, they estimate that in sub-Saharan Africa, reduction in access to effective antimalarial treatment of 10 per cent could lead to an additional 19,000 deaths by the end of 2020.

More For You

Impact of National Insurance rise on community pharmacies.

Pharmacies are faced with higher NI payments

Pic credit: Istock

Pharmacies to pay higher national insurance contributions after MPs refuse to back amendments to bill


Community pharmacies are faced with paying the higher rate of national insurance contributions that come into force next month after MPs on Wednesday (19) rejected amendments to a bill that was approved by the House of Lords.

Keep ReadingShow less
Novo Nordisk regains ABPI membership after two-year suspension

Novo Nordisk was suspended in March 2023 for sponsoring pharmacy weight management training courses.

Image Credit: Novo Nordisk

Novo Nordisk’s ABPI suspension lifted after two years

Novo Nordisk has regained full membership of the Association of the British Pharmaceutical Industry (ABPI) after a two-year suspension due to serious breaches of the ABPI Code of Practice.

The reinstatement follows rigorous audits of the company’s compliance procedures and governance by the Prescription Medicines Code of Practice Authority (PMCPA).

Keep ReadingShow less
NICE calls for annual BMI checks for adults with long-term conditions

Annual BMI measurements create early intervention opportunities for weight management

Getty Images

NICE seeks feedback on annual BMI checks for adults with long-term conditions

The National Institute for Health and Care Excellence (NICE) has published a draft quality standard recommending annual Body mass index (BMI) and waist-to-height measurements for adults with long-term conditions to help prevent weight-related complications.

A consultation has been launched to gather feedback from healthcare professionals and commissioners on the feasibility of implementing these proposals within the NHS.

Keep ReadingShow less
Medicine shortages: Penny-pinching costs taxpayers more, warns CCA

Pharmacies are forced to dispense medicines at a loss or face stock shortages.

Getty Images

Government’s penny-pinching approach driving medicine shortages, CCA warns

The Company Chemists’ Association (CCA) has warned the government's longstanding drive to save pennies on the medicines bill is leading to avoidable medicine shortages, ultimately costing taxpayers more.

In a newly released paper, the CCA highlighted how the government has squeezed the price it is willing to pay for many medicines, making the UK a less attractive market for pharmaceutical manufacturers and suppliers.

Keep ReadingShow less
Morrison: Pharmacy contract news

Janet Morrison

Morrison: Pharmacy contract news “before the start of the financial year”


Community pharmacies will get clarity over a new funding contract before the start of the financial year, according to Community Pharmacy England (CPE) chief executive Janet Morrison.

Keep ReadingShow less